康辰药业控股股东刘建华拟减持不超3%公司股份

Core Viewpoint - Kangchen Pharmaceutical (603590) announced that its controlling shareholder, Liu Jianhua, plans to reduce his stake in the company due to personal funding needs, with a total reduction not exceeding 4.78 million shares, which is 3% of the company's total shares [1] Group 1 - The announcement was made on the evening of September 5 [1] - The reduction will occur through centralized bidding and block trading methods [1] - The total number of shares Liu Jianhua intends to sell is capped at 4.78 million [1]